期刊文献+

辛伐他汀联合依折麦布的临床应用进展 被引量:2

原文传递
导出
摘要 心血管疾病与脂质紊乱有着极其紧密的联系,在治疗过程中降低低密度脂蛋白胆固醇(LDL-C)的水平,可以显著降低冠状动脉疾病(CAD)和急性心血管事件的发病率和致死率。他汀类药物有着良好的降LDL—C效果。最近研究还发现,他汀类药物还具有改善血管内皮功能和抗炎的特性,这些都提示他汀类药物可能对动脉粥样硬化也有治疗作用,同时其改善血管功能和凋节炎性反应的作用已经成为了研究的热点。但是,随着他汀类药物的广泛应用,
作者 张力华
出处 《中国药房》 CAS CSCD 北大核心 2010年第24期2298-2300,共3页 China Pharmacy
  • 相关文献

参考文献20

  • 1Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, et al. The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients [J]. Atherosclerosis, 2009, 202(1): 216.
  • 2Olijhoek JK, Hajer GR, van der Graaf Y, et al, The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial [J]. J Cardiovasc Pharmacol, 2008, 52(2): 145.
  • 3Davidson MH, McGarry T, Bettis R, et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia [J]. J Am Coll Cardiol, 2002,40 (12) : 2 125.
  • 4Maki-Petaja KM, Booth AD, Hall FC, et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis [J]. J Am Coil Cardiol, 2007, 50 (9) : 852.
  • 5Kastelein JJ, Akdim F, Stroes ES, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia [J]. NEnglJMed, 2008, 358(14): 1 431.
  • 6Peto R, Emberson J, Landray M, et al. Analyses of cancer data from three ezetimibe trials [J]. N Engl J Med, 2008, 359(13) : 1 357.
  • 7Pedersen TR, Tobert JA. Simvastatin: a review [J]. Expert Opin Pharmacother, 2004, 5(12) : 2 583.
  • 8Capps N. Total and low-density lipoprotein cholesterol responses to ezetimibe in clinical practice [J]. Int J Clin Pract, 2006, 60(7): 867.
  • 9Pearson TA, Denke MA, McBride PE, et al. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP IlI goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial [J]. Mayo Clin Proc, 2005, 80(5): 587.
  • 10Ballantyne CM, Abate N, Yuan Z, et al. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study [ J]. Am Heart J, 2005, 149(3): 464.

同被引文献26

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2何甲均,徐学广,郑莘.辛伐他汀和盐酸小檗碱治疗高脂血症和颈动脉粥样硬化的疗效[J].天津医药,2007,35(7):539-541. 被引量:3
  • 3中华人民共和国卫生部药政管理局.新药(西药)临床研究指导原则[M].北京:人民卫生出版社,1993:51.
  • 4Filippatos TD, Randeva HS, Derdemezis CS, el al. Visfatin/ PBEF and atherosclerosis related diseases J 1. Curr Vase Pharmacol, 2010, 8(1) :12 28.
  • 5Dahl TB, Yndcstad A, Skjelland M, el al. Increased expres sion of visfatin in macrophages of hun,an unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization [J. Circulation, 2007, 115 (8) : 972- 980.
  • 6Hah YJ, Kim NK, Kim MK, el al. Relationship hetween Chemerin Lords and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease[J]. Diabetes Metab ,1, 2011, 35 (3) = 248 254.
  • 7Gensini GG. A more meaningful scoring system for determi ning the severity of coronary heart discasc[J]. Am J Cardiol, 1983, 51(3):606.
  • 8Stofkova A. Resistin and visfatin: regulators of insulin sensi tivity, inflammation and immunity[J]. Endocr Regul, 2010, 44(1):25 36.
  • 9Filippatos TD, Randew HS, Derdemezis CS, el al. Visfatin/ PBEF and atherosclerosis related diseases -J . Curr Vase Pharmacol, 20 10, 8 ( 1 ) : 12 28.
  • 10Kadoglou NP, Gkontopoulos A, Kapelouzou A, el al. Serum levels of vaspin and visfatin in patients with coronary artery diseaseKozanistudyJ. ClinChimActa, 2011,412(1 2):48 52.

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部